Novel vaccine promising in treatment of genital warts

Baltimore - Phase II study results point to the potential roleof HspE7 as a safe and effective immunotherapeutic agent for the treatmentof genital warts and other HPV-related sexually transmitted diseases, KeertiV. Shah, M.D., said.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.